MECHANISM OF MATRIX VESICLE BIOGENESIS
基质囊泡生物发生机制
基本信息
- 批准号:6044765
- 负责人:
- 金额:$ 26.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-02-01 至 2005-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (adapted from the Investigator's abstract): Vertebrate
biomineralization begins when Matrix vesicles (MV) are budded from the plasma
membrane of osteoblasts and chondrocytes prior to the onset of matrix
mineralization in cartilage and bone. MV contain a specific subset of the
protein and lipid constituents of the parent cell plasma membrane, and are
believed to initiate matrix calcification. The mechanisms which carry out and
control MV biogenesis are not currently understood. The experiments described
in this application are aimed at providing crucial new information in this
important and thus far under studied area. The principle goal of this proposal
is to test four hypotheses of MV formation: 1. MV arise as a consequence
chondrocyte apoptosis, 2. MV bud from plasma membranes as the result of
overexpression of MV proteins, 3. MV form in response to a rise in [Ca2+]I and
4. Cells bud off MV as the result of specific changes in membrane lipid
composition. The investigators propose to test these hypotheses against two
gold-standard criteria for authentic MV: 1. Do vesicles formed by each of the
hypothetical mechanisms contain the same protein and lipid constituents as
tissue-derived MV, and 2. How well can these vesicles initiate mineralization.
They will also ascertain the spacial and temporal occurrence of each of the
hypothetical mechanisms in developing mineralized tissues, and relate this
pattern to the emergence of MV in the tissue. To achieve these goals and test
these hypotheses, they propose the following specific aims: to determine
whether vesicles formed during chondrocyte apoptosis are MV, to ascertain
whether overexpression of MV proteins can initiate MV formation, to determine
how modulation of intracellular calcium regulates MV formation in osteoblasts
and chondrocytes, to determine whether MV formation is driven by specific
changes in plasma membrane lipid composition. The successful completion of this
work will advance our knowledge of the regulation of hard tissue formation.
This information is crucial for developing new approaches to metabolic bone
diseases such as Pagets's disease of bone and osteoporosis, and may also
contribute to novel therapies for the repair of craniofacial defects and
fracture.
描述(改编自研究者摘要):脊椎动物
当基质囊泡(MV)从血浆中出芽时,生物矿化开始
成骨细胞和软骨细胞的膜在基质出现之前
软骨和骨中的矿化。MV包含一个特定的子集,
蛋白质和脂质成分的母细胞质膜,并
被认为是引起基质钙化的原因。执行和
控制MV生物发生目前还不清楚。描述的实验
旨在提供关键的新信息,
这是一个重要的,迄今尚未研究的领域。本提案的主要目标是
是为了测试MV形成的四个假设:1。因此,MV出现
软骨细胞凋亡; 2. MV芽从质膜作为结果
MV蛋白的过表达,3. MV形式响应于[Ca 2 +]I的升高,
4.由于膜脂的特殊变化,细胞从MV中出芽
混合物.研究人员建议用两种方法来检验这些假设。
真实MV的黄金标准:1.每一个细胞形成的囊泡
假设的机制包含相同的蛋白质和脂质成分,
组织来源的MV,和2.这些囊泡如何启动矿化。
他们还将确定每一个事件的空间和时间发生情况,
假设的机制,在发展矿化组织,并与此相关,
在组织中出现MV的模式。为了实现这些目标,
这些假设,他们提出了以下具体目标:
软骨细胞凋亡过程中形成的囊泡是否为MV,以确定
MV蛋白的过表达是否可以启动MV形成,以确定
成骨细胞内钙离子的调节如何调节MV的形成
和软骨细胞,以确定MV的形成是否是由特定的
质膜脂质组成的变化。成功完成本
这项工作将促进我们对硬组织形成的调节的认识。
这些信息对于开发新的代谢骨方法至关重要
疾病如佩吉特氏骨病和骨质疏松症,并且还可以
有助于修复颅面缺损的新疗法,
骨折
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELLIS E GOLUB其他文献
ELLIS E GOLUB的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELLIS E GOLUB', 18)}}的其他基金
相似国自然基金
Calcium/NFAT/GLUT3通路调控糖酵解代谢在CAR-T细胞耗竭中的作用和机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
miR-30调控Calcium/Calcineurin通路在慢性肾脏病心肌保护中的作用
- 批准号:81670699
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
水稻OsCAS(Calcium-sensing Receptor)基因的功能分析
- 批准号:30900771
- 批准年份:2009
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
zero-CO2 cemeNt ThRough cArBonation of cAlcium Silicates and aluminateS (Contrabass)
通过硅酸钙和铝酸盐的碳化生产零二氧化碳水泥(Contrabass)
- 批准号:
EP/Y030354/1 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Research Grant
CONTRABASS - zero-CO2 cemeNt ThRough cArBonation of cAlcium Silicates and aluminateS
CONTRABASS - 通过硅酸钙和铝酸盐碳化生产的零二氧化碳水泥
- 批准号:
EP/Y031989/1 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Research Grant
NSF Convergence Accelerator Track M: A new biomanufacturing process for making precipitated calcium carbonate and plant-based compounds that support human health
NSF Convergence Accelerator Track M:一种新的生物制造工艺,用于制造支持人类健康的沉淀碳酸钙和植物基化合物
- 批准号:
2344228 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Standard Grant
DEL-1 Promotes Biogenesis of Mineralizing Extracellular Vesicles by Mediating Intracellular Calcium Signaling
DEL-1 通过介导细胞内钙信号传导促进矿化细胞外囊泡的生物合成
- 批准号:
24K19876 - 财政年份:2024
- 资助金额:
$ 26.93万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The development of targeterd therapies for Intra-mitochondrial calcium ion dinamics in colorectal cancer stem cells
结直肠癌干细胞线粒体内钙离子动态靶向疗法的开发
- 批准号:
23K06654 - 财政年份:2023
- 资助金额:
$ 26.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Muscle contraction and calcium signaling
肌肉收缩和钙信号传导
- 批准号:
23K10634 - 财政年份:2023
- 资助金额:
$ 26.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
RUI: Allosteric Activators of the Sarco/Endoplasmic Reticulum Calcium ATPase
RUI:肌瘤/内质网钙 ATP 酶的变构激活剂
- 批准号:
2327946 - 财政年份:2023
- 资助金额:
$ 26.93万 - 项目类别:
Standard Grant
Understanding the cellular response to calcium influx based on endoplasmic reticulum-mitochondria interaction
基于内质网-线粒体相互作用了解细胞对钙流入的反应
- 批准号:
22KJ3086 - 财政年份:2023
- 资助金额:
$ 26.93万 - 项目类别:
Grant-in-Aid for JSPS Fellows
In vivo calcium imaging during appetitive learning in HIV Tat transgenic mice exposed to cannabis
暴露于大麻的 HIV Tat 转基因小鼠食欲学习过程中的体内钙成像
- 批准号:
10696442 - 财政年份:2023
- 资助金额:
$ 26.93万 - 项目类别:














{{item.name}}会员




